News
-
-
-
REGULATED PRESS RELEASE
EURAZEO PARTICIPATES IN GERMITEC’S EUR 29 MILLION SERIES B FUNDRAISING
Eurazeo participates in Germitec’s €29 million Series B fundraising to support the development of innovative High-Level Disinfection solutions for ultrasound probes. Nov Santé Actions Non Cotées is the lead investor -
-
-
-
REGULATED PRESS RELEASE
Déclaration du nombre d'actions composant le capital et du nombre total de droits de vote au 31 janvier 2025
EURAZEO communique le nombre d'actions et de droits de vote au 31 janvier 2025, illustrant sa solide structure financière. Découvrez les détails et sa stratégie d'investissement -
REGULATED PRESS RELEASE
Disclosure of the number of shares and the total number of voting rights as of January 31, 2025
Eurazeo discloses total shares and voting rights. Leading European investment group with diverse assets of 35.5 billion euros, focusing on private equity, private debt, real estate, and infrastructure -
REGULATED PRESS RELEASE
Disclosure of transactions in own shares from February 3 to February 7, 2025
-
REGULATED PRESS RELEASE
Déclaration hebdomadaire d'opérations effectuées du 3 au 7 février 2025